Hertel, Tom2009-09-182009-09-182009-09-18https://hdl.handle.net/11299/53691The information provided in this handout does not necessarily reflect the views of the University of Minnesota Medical School physicians and faculty. These materials are provided for informational purposes only and are in no way intended to take the place of the advice and recommendations of your personal health care provider. You use the information provided in these handouts at your own risk.Though Bismuth‐based Quadruple therapy is the most widely accepted salvage therapy for persistent H. pylori infection, Levofloxacin‐based Triple therapy has been proven more effective at curing the infection.en-USH. pyloridrug therapydrug resistancepeptic ulcerslevofloxacinOther